MPPED1 and benign prostatic hyperplasia: A UK Biobank‐based GWAS confirmed an increased OR for SNPs at PGR (OR 1.36), whilst additionally revealing two SNPs protective against prostate enlargement symptomatology [25], nearby other genes including MPPED1 and NPAP1 (OR 0.72 and 0.66, respectively).